CD4 and neoplasm: According to present knowledge, the ideal composition of TCR-T in terms of CTX CD4+ and CD8+ T cell presence and ratio remains questionable and is likely to differ according to either the MHC context or evaluated tumor model, regarding efficiency indicators.